Novus Expands Its Reach in the Rapidly Growing Cannabis Ancillary Sector 

About this update from Novus Acquisition & Development Corp.

Integrating Prescription Drug Plans with Cannabis Benefits by Leveraging D2C Technology Novus Acquisition & Development Corp, operating as Novus Cannabis MedPlan (OTC: NDEV ), is a leading national carrier of supplemental health insurance plans and a pioneer in incorporating cannabis coverage for recreational and medicinal users. Novus is strategically positioned in the top-performing sectors of cannabis market technology and insurance. By integrating direct-to-consumer (D2C) technology and new health plan strategies, Novus aims to attract new customers and retain existing ones. Here’s how we plan to achieve this. Key Growth Drivers for Novus As a Tier III entity in the cannabis sector, Novus operates in a low-risk category. This tier includes Marijuana-Related Businesses that do not handle the cannabis plant directly and are not significantly affected by federal regulatory setbacks. Novus excels in the leading two areas of Tier III. Cannabis Insurance: This sector is projected a CAGR of 14.14% between 2025 and 2032, the cannabis insurance market is ripe for expansion. Novus is seizing this opportunity by incorporating cannabis coverage into health plans and developing innovative insurance solutions for cannabis businesses. Cannabis Technology: This sector is projected to reach USD 20.01 billion by 2031, with a CAGR of 25.4%. Novus's innovative D2C business model allows cannabis businesses and brands to sell their products at no cost. It also gives them the tools to manage inventory, track sales, and maintain data for business efficiency. Synergistic Benefits of Being In Two Sectors  Prescription Drug Plan: Novus's platform can capitalize on the growing consumer preference for cannabis benefits and add traditional prescription drugs. The platform facilitates direct customer acquisition, boosts premium sales, retains the consumer, and creates a new revenue stream for cannabis businesses through a streamlined enrollment process and revenue-sharing opportunities. Deepening Expansion into the Recreational Market: As regulations evolve, having a presence in the recreational sector will position Novus for significant growth. Currently focused on the medical cannabis sector, Novus recognizes the emerging demand for wellness plans in the recreational market. Expanding our platform to include recreational dispensaries will not only broaden our customer base but also pave the way for further expansion into the recreational marketplace for insurance plans. Financial Highlights Novus's financial performance, as indicated in their 2024 10K, marked by increases in gross revenue and EBITDA, underscores its resilience and potential for sustained growth. The company's focus on increasing shareholder equity and maintaining healthy cash reserves demonstrates its commitment to long-term value creation. Review 2024 10K Here Long-Term Vision For Value Novus's strategic focus on technology and insurance aligns with the cannabis industry's long-term trajectory. As the industry matures and regulations evolve, companies that provide essential ancillary services will become increasingly valuable. Novus' forward-thinking approach and commitment to innovation position it as a key player in the future of cannabis. Novus's D2C platform with insurance offerings generates multiple revenue streams, fosters brand loyalty, and enables tailored insurance solutions, creating a larger market share. Additionally,  Novus's deepening expansion into the recreational cannabis market demonstrates its adaptability and commitment to meet evolving consumer needs, allowing it to tap into a wider customer base and capitalize on growing acceptance and legalization. About Novus Further Research: Financial Filings:  Click Here Quote: Click Here Investor's Page : Click Here  Novus (NDEV) operates through its wholly-owned subsidiary, WCIG Insurance Services, Inc. The company provides health plans as a health insurance carrier in states with legal medical marijuana programs. Novus' business model is based on receiving insurance premiums and does not involve the cultivation, distribution, or sale of cannabis or cannabis-related products. Novus' business model is based on the Benefit Monetization Ratio , which shows monetization premiums annually on its balance sheet. Forward-Looking Statements This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.     Investor Contact Information Investor Website 855-228-7355

View stock analysis, news, and events for Novus Acquisition & Development Corp.